How technology helped Houston fight against the pandemic

guest column

Here's what Houston tech is making a difference locally amid the pandemic. Photo via Getty Images

The entire world came to a standstill when the COVID-19 pandemic came knocking at the door, and Houston was no different than the rest. Businesses got shut down, people were losing jobs left and right, the medical infrastructure was wheezing from the huge patient-influx, and whatnot.

However, the Space City managed to weather the storm thanks to its firm resolve and technological interventions from Houston-based businesses and several other players. But that doesn't mean we are out of the woods yet.

The silver lining, however, is that we now know the threat can be mitigated with the help of technologies at our disposal. In this article, we'll discuss how technology has facilitated the fight against the pandemic. Some of the local businesses from Houston also had a significant role to play in providing an arsenal for this war, and we'll be discussing their contribution as well. So let's get started:

Remote healthcare assistance with smart data collection and management

The biggest challenge at the beginning of the pandemic was to provide proper care to those exposed to the virus without putting the lives of frontline workers in danger. On top of that, hospitals also had to make sure that patients suffering from other illnesses do not come into contact with the virus.

With the number of patients rising exponentially, the medical infrastructure could've never been able to cope up if it were not for telemedicine. It's a combination of remote and data technologies that allow healthcare workers to assist and treat patients without going in their physical proximity.

Houston's Medical Informatics Corp. did some exceptional work in making remote healthcare a feasible option for medical institutions. Their solution aims at collecting accurate and comprehensive data that'll further allow physicians to provide better care to the patients. While the luxury of social distancing is among the most significant benefits of this solution, there are several other benefits in the long run.

Since MIC's solution focuses on collecting quality data from all the possible data points, the information can also help identify any significant trends in how the virus is affecting the patients. Artificial intelligence and machine learning seem like the perfect allies to bolster MIC's solution further.

The tech also allows for patients to get quality consultation from experts located in other geographical locations. Hospitals can also leverage such an infrastructure to scale up and down with ease by quickly bringing in more remote caregivers in case of a spike in patients' numbers.

Telemedicine has been brilliant in helping the world deal with the coronavirus pandemic and paved the way for a revamped healthcare infrastructure in the future. The one in which affordable healthcare is a norm and physical distances are not an issue anymore.

Drones and robots for sanitization and upkeep

Once the lockdown restrictions were slowly uplifted, businesses needed to be more cautious about sanitizing the facilities and ensure there was no reason forcing them to close the shop again. The challenge turned out to be bigger for larger facilities as they can't simply deploy a large workforce to take care of it. It would be impossible to follow social distancing norms under such circumstances.

Many stadiums in Houston concluded that employing drones for the job is the way to go, and they couldn't have been more correct. Texas Medical Technology used 'SaniDrones' to spray disinfectants over large facilities and equipment. These drones are pretty much like what is used for agricultural fields and carry large amounts of spraying material at a time to get the job done.

The company also has an army of various other robots that can help businesses abide by pandemic norms. They have one that automatically puts protective coverings on the visitor's shoes to help prevent outside elements from entering the facility. Then they also have a robot that can take orders from customers in restaurants. It can show them 3-D menus and expertly ask customers what they'd like to order. They also offer SaniGate, which disinfect visitors before entering the premises, thus curbing the spread of the virus.

Airobotics is another Houston-based company coming up with technologically advanced solutions for businesses to deal with the pandemic. They provide drones to industrial players, such as oil and gas companies, to monitor and inspect the facility. The drones collect information critical to such plants' smooth functioning and prevent the analysts from going around and touching surfaces on the plant.

The pandemic made us realize that we can't always rely on human workers to care for the fieldwork. Drones and robots provide a suitable alternative to such jobs, and as these solutions get more commonplace, we can also expect them to get more affordable.

Bringing the economy back to life by keeping the virus out of the ecosystem

The economic slowdown brought by the coronavirus is unlike what most of us could even comprehend. With small businesses taking the biggest hit and a good fraction of them shutting down forever, it's necessary for the remaining ones free from the clutches of the pandemic.

And one of the better ways to do that is by minimizing the virus's spread at places where people frequent the most. One of the primary reasons for the coronavirus to be so transmissible is because of how it can travel through seemingly healthy carriers. It might cause a mild fever in some, but that usually doesn't keep people from getting out.

DataVox, a Houston based tech company, provides thermal scanners to make sure possibly infected humans stay away from the virus. The thermal scanners provided by them only check for the temperature and don't affect the privacy of those being scanned. It's a seemingly simple but effective way to deal with such a dangerous element.

Another positive news in this context is that researchers at the University of Houston have designed an air filter capable of filtering out the coronavirus to a great deal of effectiveness. Once commercially available, this can be installed in closed facilities and ensure the virus doesn't enter even through the vents.

There is no doubt that leveraging technology is the way to go forward despite how the situation unfolds. Houston is now implementing smart city solutions with the same thing in mind, and we should also be following their lead.

With a workforce of skilled software developers in Houston, and the city's rich background in technology, the adoption of tech measures should not turn out to be a tough deal. And Houston-based firms coming up with advanced solutions is only a good sign for the city.

Let's hope we'll be seeing more of these in the future, and more Houston businesses will help the city and the world fight this pandemic.

------

Colin Simpson is project manager at BlueKite Apps, which recently started its software development services in Houston.

In a post-COVID-19 world, it's time for drones and automation to shine. Photo courtesy of Airobotics

Houston drone company sees rising need for automation within the energy industry and beyond

hands free

For years, Ran Krauss has watched the drone and automation industry be overhyped and misunderstood. But due to a myriad of causes — a global pandemic that's forced workers to stay home, a oil glut that's caused energy company layoffs, and years of work pushing through new regulation — it's finally time, Kauss believes, for drone technology to take-off.

Krauss has worked in the drone industry for years and, in 2014, co-founded Airobotics, a full-service drone company, with Meir Kliner. Between COVID-19 and an oversupply of oil, energy companies, which make up most of Airobotics clients, are seeing how important automation and drone technology is.

"Everyone watched Netflix before, but the pandemic increased demand," Krauss tells InnovationMap. "For us, our ability to provide remote monitoring applications was always something of value, but obviously in times like this when staff can't get into a site, there's more significance."

The COVID-19 crisis, Krauss explains, has perhaps sped up energy companies' plans to integrate this type of technology.

"One of the effects of the pandemic is reconsidering the timeline and deployment of robotics as a whole to deal with future threats like this," he says. "The world is going to think differently about automation, robotics, and drones."

Krauss saw an opportunity for drone technology within industrial business, but wanted to take it a step further with automation. That's how he came up with the idea for a drone in a box — an idea that became Airobotics. The company's technology operates as a one-stop shop for companies looking for drone and automation technology.

Airobotics's technology includes a docking station that even has a robotic arm to replace batteries in the drone. Photo courtesy of Airobotics

The Airobotics device comes complete with a docking station that even has an automated arm to replace batteries, for instance, so limited human interaction is needed. Airobotics works with its clients to customize data collection needs, and then manages the operations as a service provider.

"As an operator, we figured out that we needed to create an automated system — similar to an autonomous car — for safety, productivity, and cost effectiveness. That's why we started a robotics company," he says.

While Airobotics — which has clients worldwide — has offices in the United States, Israel, and Singapore, Texas is a focus for the company, Krauss says.

The company's technology has seen historic approval from regulators in each of the countries it operates in. Specifically, Krauss praises what the Federal Aviation Administration is doing to advance drone technology regulation, and the department recognizes Airobotics as subject matter experts.

"We're working very closely with the FAA, which has identified us as a partner to help them create the right environment for drones to be integrated into the airspace," Krauss says. "You can't ignore new technologies but just saying, 'OK, this thing [isn't allowed to] fly.' There has to be the right balance of public safety and encouraging new technologies to take place."

It's not only industry and regulatory support Airobotic has seen. The company has gone through quite a few funding rounds and raised over $110 million.

"Our investors have identified the situation and the market potential our company has over anybody else," Krauss says. "We're the trailblazers, which comes at a cost — it's much easier to follow than to lead. But, we're happy to do so."

Perhaps, one of the biggest challenges for the company and the industry is educating potential clients. The word "drone" is used to describe everything from a remote-controlled device with a camera on it that's just a few hundred dollars online to Airobotics's Optimus device, which is made up of thousands of parts.

"There is definitely a constant need for market education in this sector — always has been the case," Krauss says.

For Krauss, he's seen drone technology go through this "hype phase," and he sees a bright future for what drone and automation capabilities are coming.

"I think we're going to see a resurgence in this industry in the coming years — with applications in the real world with real value generation, not just hype and science fiction," he says.

One industry that's ripe for drone technology disruption — smart cities innovation. Krauss says he hopes Houston is a city that looks to utilize the tech.

"I think the digitization of the urban environment is going to be the next sector where we're going see drones create a lot of value," he says.

Airobotics has clients within the industrial sector. Photo courtesy of Airobotics

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

4 Houston health tech startups advancing medical innovation

meet the finalists

Houston has been driving medical innovation for decades. And thanks to leading hospitals, cutting-edge research and breakthrough technologies, the region’s healthcare ecosystem continues to improve how patients are diagnosed, treated and cared for.

The Health Tech Business category in our 2025 Houston Innovation Awards will honor an innovative startup within the health and medical technology sectors.

Four forward-thinking businesses have been named finalists for the 2026 award. This year's finalists, selected by our esteemed panel of judges, range from a startup developing miniaturized medical technologies for space to a company using AI to help develop cancer treatment plans.

Read more about these businesses, their innovative founders, and how they're shaping the future of health care below.. The 2026 winners will be announced on InnovationMap.com in mid-November.

Bairitone Health

Bairitone Health is bringing anatomy imaging for sleep apnea to the home environment. The company's platform maps users' anatomy during natural sleep using a facial patch to determine the root cause of airway obstruction. It then offers effective therapies for each patient.

The company was founded in 2022 in the Texas Medical Center's Biodesign program by CEO Meagan Pitcher, CTO Onur Kilic and chief medical officer Britt Cross. It was a member of Activate Houston's inaugural cohort and has participated in numerous accelerators and incubators. The company raised an oversubscribed seed round for $2.4 million earlier this year and received Breakthrough Device Designation from the Food and Drug Administration in April.

InformAI Inc.

InformAI Inc. develops fit-to-purpose AI solutions for the clinical setting. Its RadOncAI product recently received FDA 510(k) clearance. The product uses AI to create a first-pass radiation therapy dose plan for complex head and neck cancers in an effort to eliminate bottlenecks in radiation planning and ultimately cancer treatment. The company has also developed AI products for sinus disease detection and 3D organ reconstruction.

CEO Jim Havelka founded the company in 2017. It is participating in the Mayo Clinic Accelerate Platform. It has raised about $4 million in seed funding and has received numerous non-dilutive grants from the National Science Foundation, the National Institutes of Health and the Cancer Prevention and Research Institute of Texas. The company shared in its application that it plans to launch a Series A fundraising round and submit an FDA 510K application for its organ reconstruction product, Voluquant, by the end of 2026.

Prana Surgical

Prana Surgical is developing a minimally invasive surgical platform for small, hard-to-reach lung nodules that may be cancerous. The company's Prana System cleared U.S. Food and Drug Administration (FDA) approval earlier this year.

Prana Surgical was originally founded as Prana Thoracic in 2022. It has participated in numerous accelerators, including the Texas Medical Center Innovation Accelerator in 2023 and the IGNITE Health accelerator in 2022. It raised $6 million in Series A funding rounds in 2023 and 2024 , with a Series B currently ongoing. The company said in its application that it is currently moving into the next stage of clinical validation and revenue generation in the U.S., in addition to preparing its manufacturing and commercial infrastructure for broader use.

Skybound MedTech

Skybound MedTech develops technologies that aim to address the health risks of long-duration spaceflight. Its compact, miniaturized medical technologies can deliver complex therapies without a physician.

CEO Matthew Kuhn, who previously founded Taurus Vascular, founded Skybound last year. The company emerged from stealth in January after raising a $1.25 million Series A round. It plans to advance its lead dual-use platform into critical preclinical validation in November, the company shared in its application. It is currently raising a $25 million Series A round and is pursuing federal research partnerships with DARPA and ARPA-H.

Generation Park lands new facility to scale xeno-organ production

Organ innovation

Maryland-based United Therapeutics Corp. has opened a new 77,448-square-foot facility to manufacture xeno-organs in Northeast Houston’s growing biotech hub, Generation Park.

The new Houston location is United Therapeutics’ third Designated Pathogen-Free (DPF) site, named for transplant pioneers Dr. Bartley P. Griffith and Dr. Robert A. Montgomery. The company says the new facility will enable it to scale commercial production of its xeno-organs once they receive regulatory approval.

An existing DPF facility in Virginia is supporting clinical trials for the xeno-organs, and a third site in Minnesota will also focus on commercialization with the Houston site, according to the company.

Xeno-organs are organs taken from a non-human animal source and transplanted, implanted or infused into a human recipient.

Currently, United Therapeutics is advancing clinical trials to support a Biologics License Application with the U.S. Food and Drug Administration for its investigational-stage xenotransplantation, UKidney, UThymoKidney and UHeart products. The products all involve working with the genes from humans and pigs.

In 2025, Chron.com reported the company was working to construct an estimated $96 million facility to breed genetically engineered animals. Head of investor relations at United Therapeutics Dewey Steadman told the Houston Business Journal in 2025 that the pigs’ DNA will be edited. In November 2024, a 53-year-old woman in Alabama received a transplanted kidney from UKidney that had 10 gene edits. She had the transplant removed in April 2025, after her body rejected it.

The Dr. Bartley P. Griffith and Dr. Robert A. Montgomery Xenograft Production Facility requires a “strictly controlled, biosecure barrier environment, including air filtration, filtered water, filtered feed supplies, and state-of-the-art decontamination entryways,” according to the company. Being pathogen-free means it includes calibrated air and water conduits to support the transplantability of xenograft products and to prevent contamination. For energy considerations, the building also features solar arrays.

“With our third xenograft production facility now open and clinical trials underway, United Therapeutics is moving closer to its goal of providing transplantable organs to the people who need them,” Martine Rothblatt, chairperson and CEO of United Therapeutics, said in a news release. “It is fitting that this facility is named for Dr. Griffith and Dr. Montgomery, whose first-in-human surgeries turned xenotransplantation from a theoretical possibility into a clinical reality.”

The facility, which wrapped construction in August, is located at 11848 Common Dock Dr. in Generation Park, which will house manufacturing sites for pharmaceutical heavyweights Bristol Myers Squibb and Eli Lilly. Last fall, Eli Lilly tapped Generation Park for its $6.5 billion manufacturing plant, and Bristol Myers Squibb made a $2.3 billion investment in August to bring its state-of-the-art site to the master-planned commercial district.

Elon Musk's SpaceX reports profit as AI and satellite businesses booms

Booming Business

SpaceX reported a bigger quarterly profit than expected on Tuesday, October 20, as its satellite communications and artificial intelligence businesses boomed.

The company, run by Elon Musk, posted a profit for the three months through September 2026 of $4.4 billion, or 35 cents per share, reversing a year-ago loss and easily topping Wall Street's expectations. Revenue soared to $14.6 billion, up 161%.

On a conference call with analysts, Musk suggested a merger with his electric car company Tesla might be in the works, something that has been rumored for months. He said both companies formed “special committees” of independent directors to discuss the issue, though he played down the chances of an imminent deal.

“Some people out there assume that a SpaceX and Tesla merger is a certainty,” he said. “I think that would be overstating it.”

The AI business became SpaceX's largest by revenue in the third quarter, although the Starlink satellite service remains the biggest profit generator.

“They beat across all metrics and the Starlink business looks to be accelerating,” said Dan Ives, an analyst at Yorkville Ives. “This is just what (Wall) Street wanted.”

The stock rose 7.5% in after-hours trading.

Musk also told analysts that for next month's launch of its Starship rocket, SpaceX will attempt to grab both the booster and ship with mechanical arms upon return to base, a key step toward demonstrating it can reuse the massive spacecraft.

“The only way that we can extend consciousness beyond Earth on a sustained basis is with a fully reusable orbital launch vehicle,” Musk said, calling the attempt, if successful, “a massive technology milestone.”

SpaceX hopes to get Starship on a regular launch pattern in preparation for NASA's upcoming lunar missions.

The company already has huge contracts with the federal government, and House Democrats have called for investigations into those contracts and Musk’s work with the Department of Government Efficiency. Musk has spent $276 million since July in support of Republican candidates.

In a filing for its initial public offering in June, SpaceX warned that a change in control of Congress could have a “material and adverse impact on our growth and competitive position.”

Musk recently drew criticism from politicians in Washington after speeds for a military version of SpaceX's satellite communications service were slowed for Ukraine following President Donald Trump's deal to get more diesel oil from Russia amid a push to end the war. The Wall Street Journal reported Tuesday that it was Musk who ordered the slowdown, impeding Ukraine’s use of drones along the front. SpaceX did not immediately respond to an Associated Press request for comment on the Journal story.

Both Trump and Musk have denied responsibility for the slowdown.

As midterm elections near, Musk on Monday promised to give one share of SpaceX to “every kid in America” next year, though he provided no details on how the distribution would be carried out. With communities nationwide protesting the construction of large data centers and concerns about AI safety, AI companies are trying to build goodwill. Anthropic pledged to commit 5% of its shares to a new “public benefit” fund.

SpaceX shares have been under pressure over concerns that the company was spending too much on major projects to compete with rivals such as Anthropic. The company said capital expenditures totaled $19.6 billion last quarter, nearly triple the figure from a year earlier, and it forecast spending would grow to $35 billion to $40 billion in the current quarter.

Shares of SpaceX closed Tuesday at $147.79, down from a peak near $201 after its IPO, which made Musk the world’s first trillionaire at the time. But the share prices for SpaceX and Tesla have since dropped, reducing his net worth to $925 billion, according to Forbes magazine.

Tesla reports third-quarter financial results Wednesday. Last week, Tesla unveiled a new Roadster sports car that in some versions may include thrusters allowing it to briefly fly using SpaceX technology — though experts say anything usable for drivers is a long shot.

View All Listings